
The Future of AI in Healthcare Depends on Clinical Data Quality Assessment
Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry.
Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry.
If healthcare leaders hope to demonstrate ROI on AI investments, reduce clinician burnout, and meet compliance requirements, they must first ensure the integrity of their clinical data.
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup.
A direct-to-patient model for observational research will ease the participation burden, better incorporate the patient voice, and empower individuals to take control of their health – all while meeting the growing demands for robust evidence in developing new drugs and therapeutics.
As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency.
Providing a clear and unwavering roadmap of anticipated milestones will ensure that no matter the inevitable bumps or detours, your stakeholders can always see the path forward and track your progress.
Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.
Data can help healthcare facilities improve patient safety, but first, healthcare leaders need to bring data from multiple sources together using a common taxonomy.
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine. The company's mission is to leverage its two institutional partners’ deep data resources to create more useful data that enables quicker discoveries of new diagnostics and medical interventions.
Digital health company Verana Health has raised $150 million. The company said it will use the new capital to expand its technology, which is used by physicians and pharmaceutical companies.
Co-led by Kaiser Permanente, the Series D financing round will enable OM1 to expand its data networks into chronic disease areas, including rheumatology and behavioral health, and advance its AI analytics models.